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INTRODUCTION
Iodine intake may increase the frequency of 
thyroiditis in humans, and may induce the occur-
rence of experimental (autoimmune) thyroiditis 
(ET) in animals [1, 2, 3]. These facts have led to 
inevitable experimental studies of this serious 
disease aetiology and pathogenesis. In geneti-
cally determined thyroiditis in animals, iodine 
enrichment has been shown to increase the inci-
dence and severity of the disease. Its mechanism 
of action is still uncertain [1]. Iodine is believed 
to be the first known inhibitor of the thyroid 
gland [4, 5]. In patients with hypothyroidism 
iodide increases the formation of hormones, and 
very high doses occasionally inhibit hormone 
release and lead to gland involution, making 
the gland harder and reducing blood circula-
tion [1]. In the recent decades increased iodate 
intake [6] has been shown to enhance signifi-
cantly the frequency of autoimmune thyroid-
itis. Iodine effect on the thyroid gland is complex 
and depends on the dosage and thyroid status 
of the body [7]. Preoperative administration 
of Lugol’s solution, apart from involution, also 
causes thyroidite vacuolization and the infiltra-
tion of the interstitial space. KI is used as a drug 
in the treatment of numerous diseases, such 
as small-vessel vasculitis, erythema nodosum, 
vasculitis nodularis, Sweet’s syndrome, tubercu-
losis and granulomatosis, and for iodized salt. KI 
and potassium chloride (KCL) administered to 
rats stimulate occurrence of thyroid cancer [4]. 
Radioiodine ablation doses in the treatment of 
thyroid malignancy provoke permanent thyroid-
itis as a rule. Iodide induces the release of free 
radicals in cells and oxidative stress in thyro-
cytes and possibly in immunocompetent cells 
[8]. Lithium chloride (LiCl), potassium perchlo-
rate (KClO) and iodides of sodium (NaI) inhibit 
iodine metabolism in a dose-dependent manner, 
especially KClO in the dose of 3.5 mmol/l.
Several animal species have been known to be 
highly susceptible to the development of thyroid-
itis, as in the case of certain strains of rats and 
chickens. Large doses of iodide administered to 
BioBreeding/Worchester BB/W rats, chickens 
of the Obese strain (OS) and hamsters enhance 
the incidence of lymphocyte thyroiditis (LT) [9].
The induction of ET has been investigated 
in genetically susceptible OS with spontaneous 
development of anti-thyroid antibodies. The 
thyroid is histologically characterized by mono-
nuclear cell infiltration with the destruction of 
acini and proliferation of connective tissue, simi-
lar to chronic thyroiditis in humans [9]. The 
administration of iodide to chickens during the 
first 10 weeks of life increases the incidence of 
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thyroid gland of Wistar rats and determine the effect on hormone status (T4, T3 and TSH) in this rat strain.
Methods Two groups of rats from the Wistar strain were treated with a low iodine dose (225 µg/g BW) 
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as controls. The solution was administrated daily intraperitoneally during the period of 26 consecu­
tive days.
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ET occurrence, whereas the restriction of iodide decreases 
the development of anti-thyroid antibodies. This serious 
inflammation of the thyroid gland is followed by clinical 
and biochemical features typical of thyroiditis. BB/W rats 
spontaneously develop insulin dependent diabetes melli-
tus and LT. Studies have shown that BB/W (Saitama-Tokyo 
colony) rats develop LT around the tenth week of life. In 
these rats serum TSH level is increased during LT devel-
opment, although the level of thyroid hormones remains 
within the normal range. This means that this rat strain is 
found to have subclinical hypothyroidism [10].
OBjECTIvE
The purpose of this study was to compare the effects of low 
and high doses of KI on the thyroid gland of Wistar rats 
and to determine the effect on hormone status (T4, T3 and 
TSH) in this rat strain.
METHODS
Animals
Eight to ten week-old male rats of the Wistar strain initially 
weighing 180-200 g, were used in this study. The study 
was carried out at the Institute of Pathophysiology of the 
University of Belgrade. Three groups of 10 rats were treated: 
the first group was injected with a low iodine dose (LKI – 
225 µg/g BW) and the second with a high iodine dose (HKI 
– 675 µg/g BW) during a period of 26 consecutive days. The 
control group of animals was injected with saline solution. 
The rats were injected with specified doses of KI and NaCl 
daily, and then euthanized by exsanguination from the heart.
Histological analysis
Paraffin sections of the thyroid gland were stained with 
haematoxylin-eosin or methyl green pyronine. The intensity 
of histological lesions was classified into four grades from 
grade 0 to grade 4 as follows: 0 – normal structure; 1 – 1 or 
2 foci of infiltration; 2 – 3 or more foci of infiltration; 3 – 
diffuse infiltration with occasional destruction of follicles; 
4 – diffuse infiltration with massive destruction of follicles 
and proliferation of connective tissue [11].
Quantitative determination of T3, T4 and TSH  
in animal serum
Serum for hormone assay was obtained from blood samples 
taken by heart puncture on the 26th day after treatment 
with solution and kept on -18°C until the determination 
of hormones.
T3 and T4 concentrations were determined by a radioim-
munoassay (RIA) method of the Institute for the Application 
of Nuclear Energy in Agriculture (INEP Zemun). The RIA 
of INEP was used to determine total T3 and T4, i.e.the sum 
of bound and free hormones.
T3 and T4 determination by RIA was based on a compet-
itive binding of hormones in serum and hormones marked 
as J125 for a certain number of antigen determinants on 
antibodies specific for these hormones. Thus, radiolabelled 
and non-radiolabelled immune complexes were devel-
oped and precipitated with polyethylene glycol, while free 
hormones remained liquids. At the same time, the stan-
dards of known concentration were treated. After reaction, 
both complexes were precipitated with polyethylene glycol, 
while free hormones and free antibodies remained liquids.
The radioactivity of the precipitated complex was 
measured in a gamma ray scintillation counter. After 
completed measurement, the mean values of total activity 
(T), maximal linkage (Bo), and the value of standards and 
samples (B) were then calculated. The B/Bo ratio expressed 
as a percentage was calculated according to the formula:
B/Bo (%) = CPM/CPM (Bo) × 100; 
where CPM is the value of standards, samples or control.
Serum total T3 and T4 concentrations could be read 
directly from the standard curve.
The sensitivity of the assay was 2 nmol/l, which was calcu-
lated by exploration of the standard mistake of T4 zero 
concentration and T3 concentration of 0.027 nmol/l. The 
reference values of T4 were 55-150 nmol/l. The reference 
values of T3 were from 1.14-1.40 nmol/l.
Thyreotropin was determined by an immunoradiomet-
ric quantitative assay (IRMA). The quantity of radioactivity 
measured was directly proportional to the TSH concentra-
tion of the sample. The normal values were up to 6 mU/1, 
and the sensitivity of the assay was 0.035 mU/1.
Statistical processing of results
The difference between the experimental groups was 
analyzed by a one-way ANOVA assay. Intergroup compar-
ison was performed using the Student’s t-test.
RESULTS
Histological analysis of the thyroid gland
The thyroid gland of the untreated normal animals is shown 
in Figure 1а, and the thyroid gland of the control group of the 
same age treated with saline solution is shown in Figure 1b. 
No significant differences were found. The cross-section of 
the thyroid gland of a rat injected with low concentrated KI 
solution is shown in Figure 1. There were several preserved 
follicles along its circumference. The remaining portion of 
the gland was blurred, some remaining follicles without 
colloid and thyrocytes were observed. Infiltration of mono-
nuclear cells between the gland follicles and proliferation 
of connective tissue dividing the gland tissue into smaller 
islands are shown in Figure 1c. All thyroid glands of rats 325
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treated with HKI showed changes in terms of connective 
tissue proliferation, follicle loss and mononuclear cell infil-
tration, as shown in Figure 1d.
Table 1 presents the results of comparison of the intensity 
of histological changes in these three groups. The difference 
between them was statistically significant.
The Kruskal–Wallis analysis of variance revealed a statis-
tically highly significant difference in the intensity of histo-
logical changes among the examined groups (H=12.742; 
p<0.01). Comparing controls and the group treated with LKI 
by the Mann–Whitney U-test a statistically a highly signif-
icant difference was found (U=2; p<0.01), which was also 
the case with the group treated with HKI (U=1; p<0.01). 
The test revealed no statistically significant differences in 
animals treated with KI (U=46; p<0.05).
Hormones
Significant differences in serum T3 hormone levels (nmol/l) 
between animals of LKI and HKI groups measured at the 
end of the experiment were analyzed. A statistically signif-
icant difference in T3 level between animals of these two 
subgroups was found (p<0.05). The tests results (t-test) are 
given in Table 2. One-factor analysis of variance revealed 
no statistically significant difference in T3 level between the 
examined groups (F=0.787; p>0.05).
Significant differences in serum hormone T4 level 
(nmol/l) between animals of LKI and HKI groups measured 
at the end of the experiment were analyzed. A statistically 
significant difference in T4 level between animals of these 
two subgroups was found (p<0.01). The test results (t-test) 
are given in Table 3. The difference in T4 level between 
the examined groups was statistically highly significant 
(F=6.086; p<0.01).
Differences in serum TSH level (mU/l) between animals 
of LKI and HKI groups measured at the end of the experi-
ment were analyzed. No statistically significant difference in 
TSH level between the animals of these two subgroups was 
found; the correlation was negative (p>0.05). The test results 
(t-test) are given in Table 4. Analysis of variance revealed 
no statistically significant difference in TSH level between 
the examined groups (F=0.358; p>0.05).
DISCUSSION
Having in mind that in the recent decades increased iodate 
intake [6] has been shown to increase the frequency of auto-
immune thyroiditis, we analysed the histological changes of 
the thyroid gland after administration of KI. Animals were 
treated with different doses of KI solution, and NaCl with [12] 
or without immunization [12, 13]. In contrast to some other 
experiments on animals which have not revealed changes 
Table 4. Serum TSH levels (mU/l) in animals treated with low iodine 
dose (LKI), high iodine dose (HKI) and controls
Groups Number X±SD
LKI 10 0.17±0.03
HKI 10 0.16±0.03
Controls 9 0.18±0.05
p>0.05
Table 3. Serum hormone T4 levels (nmol/l) in animals treated with 
low iodine dose (LKI), high iodine dose (HKI) and controls
Groups Number X±SD
LKI 10 63.10±16.11
HKI 10 66.30±12.85
Controls 7 88.69±18.98
p<0.01
Table 2. Serum hormone T3 levels (nmol/l) in animals treated with 
low iodine dose (LKI), high iodine dose (HKI) and controls
Groups Number X±SD
LKI 10 0.76±0.20
HKI 10 0.80±0.16
Controls 7 0.70±0.14
p<0.05
Table 1. Intensity of histological changes of the thyroid gland in rats 
treated with low iodine dose (LKI), high iodine dose (HKI) and controls
Groups Number X±SD
LKI 10 2.6±2.5
HKI 10 2.5±0.85
Controls 7 0.33±0.52
p<0.01
Figure 1. Thyroid glands of the rats: a – nontreated controles; b – controles treated with NaCl; c – experimental group treated with LKI rest of 
follicules without colloid and thyreocytes, infiltred with mononuclear cells, with proliferation of connective tissue; d – experimental group 
treated with HKI, with proliferation of connective tissue, lost follicular architecture and mononuclear cell infiltration (H&E, 160×).
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in the gland after administration of mere iodide [14], in our 
work, in accordance with clinical findings [1, 5, 6, 11] and 
numerous experiments [3, 8, 9, 10] the gland architecture 
was seriously damaged. The pathogenesis of follicle destruc-
tion and necrosis of thyrocytes were probably induced by a 
direct toxic effect of iodine on subcellular structures, also 
suggested by LI Mu [8]. Damages in thyrocytes promote 
migrations of mononuclear cells into the gland [15], activate 
complement [12] and provoke inflammatory process since 
KI has been found to stimulate humoral immunity [12, 16]. 
After monitoring the hormonal status (TSH, T3 and T4), we 
found a difference between the treatment and control groups 
while examining T3 and T4 ratio. The difference in T3 and 
T4 levels between rat blood treated with LKI and HKI and 
controls was statistically significant.
The animals euthanized on the 26th day showed a statisti-
cally highly significant decrease in T4 level (p<0.01), which is 
in accordance with our previous study on the effect of mini-
mal dose of KI on the thyroid gland [13], analyzed on the 
10th and 17th day. Both cases showed a statistically signifi-
cant decrease in T3 level (p<0.05). The comparable values 
of T3 and T4 analyzed on the 10th and 17th day showed no 
significant differences in the levels of both hormones, when 
the 17th day was compared with the10th day. Hypothyreosis 
increased insignificantly on the 17th day. The exception was 
the group injected with KI on the 10th day when negative 
correlation was observed (p>0.05).
Based on our results, T4 level in rats treated with KI 
showed a significant decrease when compared to the control 
group level, which is in accordance with other authors’ 
findings [8, 9, 14]. Some authors have reported, however, a 
decrease of T4 without the incidence of hypothyroidism [5]. 
The fact, that on the 10th day the decrease of T3 and T4 was 
observed at daily injection of the specified dose of KI, indi-
cates that this dose could lead to manifest hypothyroidism 
in blood even quicker, although no statistical difference for 
T4 was observed [13].
The results obtained by the examination of T3 are in 
contrast to the results of other authors [17]. Namely, their 
findings revealed higher T3 levels than ours. They explained 
it by adaptive mechanisms which enhance peripheral 
conversion of T4 into T3. Low doses of hormones could be 
explained by the presence of antithyroid antibodies.
Immunohistochemical methods recorded the presence 
of antithyroid microsomal antibodies in serum and signifi-
cantly less titration [18] than one observed in earlier research 
[13]. However, differences in T3 and T4 levels showed that 
seven days were not enough to demonstrate more in-depth 
difference between T3 and T4 levels in blood of already 
hypothyroid animals.
Iodide effects on the thyroid gland are complex and 
depend upon the dosage and thyroid status of the body. 
Preoperative administration of Lugol’s solution, apart from 
the involution, also develops thyrocyte vacuolization [2] 
and infiltration of the interstitial space. KI and KCL admin-
istered orally to rats stimulate the occurrence of the thyroid 
cancer [4, 19]. Radioiodine ablation doses in the treatment of 
thyroid malignity cause permanent thyroiditis as a rule [19, 
20]. Iodides induce the release of free radicals in cells and 
oxidative stress in thyrocydes [21] and possibly in immu-
nocompetent cells.
We could agree with the hypothesis on pathogenesis 
of lymphocite thyroiditis [11, 22, 23] that environmental 
factors, iodides, alone or combined with increased TSH level 
or with a virus may damage the thyroid. The damage induced 
by iodides associated with hydroxyl radicals is highly severe 
in sensitive chicken strains [11]. This is followed by the 
occurrence of numerous phenomena, for example mono-
cytes secrete interleukin 1 which exerts a direct cytotoxic 
effect on thyrocytes and thereby provide signals to CD4+ 
cells [2]. T and B lymphocytes migrate into the damaged 
thyroid, recognize sequestered antigen thyroglobulin as 
foreign, activate complement and elicit inflammation – 
thyroiditis [15, 20, 22].
CONCLUSION
Iodide effects on the thyroid gland are complex and depend 
upon the dosage and thyroid status of the body. By monitor-
ing hormone status (TSH, T3 and T4) and morphological 
changes it was found that therapeutic doses of KI applied in 
treatment induce occurrence of experimental thyroiditis (like 
chronic destructive Hashimoto’s thyroiditis in humans) and 
necrosis of cells in animals not carrying a genetic suscepti-
bility. Significant inflammatory changes were observed in 
rats treated with HKI.
Early iodine induced cell necrosis and inflammation in 
the nonimmunized animals without the genetic susceptibil-
ity is in fact a new experimental model of the LT.
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KRATAK SADRŽAJ
Uvod K a  l i  j u m ­ j o  d i d  (KI)  s e  p r i  m e  wu  j e  u  l e  č e  wu  m n o  g i h  b o  l e  s t i ,  
kao što su va  sku  li  tis ma  lih krv  nih su  do  va, erythe ma no do sum, 
vas cu li tis  no du la ris, Svi  tov (Swe et)   s i n  d r o m ,   t u  b e r  k u  l o  z a   i   g r a ­
n u  l o  m a  t o z a ,  k a o  i  z a  j o  d i  r a  w e  s o  l i .  I s t o  v r e  m e  n o  KI m o  ž e  b i  t i  
š t e  t a n .  Un o  š e  w e  j o  d i  d a  k o d  qu d i  p o  v e  ć a  v a  u č e  s t a  l o s t  o b o  l e ­
v a  w a  o d  t i  r e  o  i  d i  t i  s a ,  a  k o d  l a  b o  r a  t o  r i j  s k i h  ž i  v o  t i  w a  i z a  z i ­
v a  t z v .  e k s  p e  r i  m e n  t a l  n i  t i  r e  o  i  d i  t i s .  I s  p i  t i  v a  w a  t i  r e  o  i  d i ­
t i  s a  k o d  p a  c o  v a  s o  j a  Wi star s u  j a  s n o  p o  k a  z a  l a  d a  s u  m o r  f o  l o  š k e  
pro  me  ne na wi  ho  voj štit  astoj žlezdi iza  zva  ne pri  me  nom KI.
Ciq ra da Ciq is tra ži va wa je bio da se upo re de efek ti pri­
m e  n e   m a  l e   i   v e  l i  k e   d o  z e   KI na šti  ta  stu žle  zdu Wi star  p a  c o  v a  
i usta  no  vi uti  caj KI na wi  hov hor  mon  ski sta  tus (T3, T4, TSH).
Me to de ra da P a  c o  v i  m a  s o  j a  Wi star ubri zgan je KI u ni skoj kon­
c e n  t r a  c i  j i   (2 2 5   µg/g  t e  l e  s n e   m a  s e)   i   v i  s o  k o j   k o n  c e n  t r a  c i  j i  
(675 µg/g  t e  l e  s n e   m a  s e) .   N e  t r e  t i  r a  n e   n e  i  m u  n i  z o  v a  n e   ž i  v o  t i ­
we slu  ži  le su kao kon  tro  la. Ras  tvor je to  kom 26 uza  stop  nih 
d a  n a   s v a  k o  d n e v  n o   u b r i  z g a  v a n   i n  t r a  p e  r i  t o  n e  a l  n o .
Re zul ta ti M e  r e  w e m  n i  v o a  TSH, T3 i T4 i  p o  s m a  t r a  w e m  m o r  f o ­
l o  š k i h  p r o  m e  n a  š t i  t a  s t e  ž l e  z d e ,  u s t a  n o  v q e  n o  j e  d a  t e  r a  p i j ­
ske do  ze KI k o  j e  s e  p r i  m e  wu  j u  z a  l e  č e  w e  i z a  z i  v a  j u  e k s  p e  r i  m e n ­
t a l  n i  t i  r e  o  i  d i  t i s  i  n e  k r o z u  ć e  l i  j a  g e  n e t  s k i  n e o  s e  t q i  v i h  ž i ­
v o  t i  w a ,   t i  p a   h r o  n i č  n o g   d e  s t r u k  t i v  n o g   H a  š i  m o  t o  v o g   t i  r e  o  i ­
d i  t i  s a  k o d  qu d i .  Z a  p a  q e w  s k e  p r o  m e  n e  ž l e  z d e  (i n  f i l  t r a  c i  j a  
m o  n o  n u  k l e  a r  n i h  ć e  l i  j a  u  r a  z o  r e  n o m  t k i  v u )  s u  b i  l e  z n a t  n o  i z ­
ra  že  ni  je kod pa  co  va ko  ji su do  bi  ja  li ve  li  ke do  ze KI.
Z a  k qu  č a k N e  k r o z a  i  z a  p a  q e  w e  i z a  z v a  n i  j o  d i  d o m  k o d  n e  i  m u  n i ­
z o  v a  n i h  ž i  v o  t i  w a ,  b e z  g e  n e t  s k e  o s e  t q i  v o  s t i ,  j e  s t e  n o v  i  o r i ­
g i  n a  l a n   e k s  p e  r i  m e n  t a l  n i   m o  d e l   t i  r e  o  i  d i  t i  s a .
K qu č  n e   r e  č i :   e k s  p e  r i  m e n  t a l  n i   t i  r e  o  i  d i  t i s ;   KI; T3; T4; TSH; 
p a  c o  v i
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